Low glycosylated ferritin is a sensitive biomarker of severe COVID-19

Cell Mol Immunol. 2020 Nov;17(11):1183-1185. doi: 10.1038/s41423-020-00544-0. Epub 2020 Sep 11.

Maxime Fauter^{1

2}, Sébastien Viel^{1

3

4}, Sabine Zaepfel⁵, Pierre Pradat⁶, Julie Fiscus⁵, Marine Villard³, Lorna Garnier³, Thierry Walzer¹, Pascal Sève², Thomas Henry¹, Yvan Jamilloux^{7

8

9}

¹ CIRI (International Centre for Research in Infectiology), Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
² Department of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, Lyon, France.
³ Immunology Laboratory, University Hospital Lyon Sud, Lyon 1 University, Lyon, France.
⁴ LIFE, Lyon Immunology Federation, Lyon, France.
⁵ Biochemistry Laboratory, University Hospital Croix-Rousse, Lyon 1 University, Lyon, France.
⁶ Centre for Clinical Research, University Hospital Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
⁷ CIRI (International Centre for Research in Infectiology), Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France. yvan.jamilloux@chu-lyon.fr.
⁸ Department of Internal Medicine, University Hospital Croix-Rousse, Lyon 1 University, Lyon, France. yvan.jamilloux@chu-lyon.fr.
⁹ LIFE, Lyon Immunology Federation, Lyon, France. yvan.jamilloux@chu-lyon.fr.

No abstract available

MeSH terms